NASDAQ:CAPR
$4.12
(
-1.67%
)
Friday, 24th Mar 2023
Capricor Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.06 | $5.22 | Friday, 24th Mar 2023 CAPR stock ended at $4.12. This is 1.67% less than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 5.17% from a day low at $4.06 to a day high of $4.27. |
| 90 days | $3.30 | $5.22 | |
| 52 weeks | $2.81 | $6.58 |
Historical Capricor Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-11 | $3.97 | $4.00 | $3.93 | $3.97 | 30 811 |
| 2023-01-10 | $3.78 | $4.04 | $3.78 | $3.95 | 106 901 |
| 2023-01-09 | $3.98 | $4.00 | $3.71 | $3.78 | 89 821 |
| 2023-01-06 | $4.02 | $4.10 | $3.85 | $3.99 | 51 300 |
| 2023-01-05 | $3.87 | $4.08 | $3.77 | $3.93 | 68 482 |
| 2023-01-04 | $3.82 | $4.09 | $3.82 | $3.95 | 88 777 |
| 2023-01-03 | $3.90 | $3.96 | $3.65 | $3.85 | 98 534 |
| 2022-12-30 | $3.77 | $3.86 | $3.76 | $3.86 | 68 246 |
| 2022-12-29 | $3.50 | $3.86 | $3.50 | $3.84 | 114 408 |
| 2022-12-28 | $3.38 | $3.54 | $3.32 | $3.50 | 75 827 |
| 2022-12-27 | $3.52 | $3.58 | $3.30 | $3.36 | 156 877 |
| 2022-12-23 | $3.56 | $3.63 | $3.45 | $3.52 | 48 552 |
| 2022-12-22 | $3.60 | $3.71 | $3.48 | $3.53 | 88 646 |
| 2022-12-21 | $3.57 | $3.82 | $3.57 | $3.65 | 79 761 |
| 2022-12-20 | $3.44 | $3.67 | $3.42 | $3.52 | 107 504 |
| 2022-12-19 | $3.75 | $3.75 | $3.42 | $3.44 | 166 006 |
| 2022-12-16 | $3.77 | $3.89 | $3.75 | $3.75 | 86 516 |
| 2022-12-15 | $3.91 | $4.02 | $3.78 | $3.89 | 109 640 |
| 2022-12-14 | $3.98 | $4.09 | $3.89 | $3.97 | 95 076 |
| 2022-12-13 | $4.09 | $4.17 | $4.02 | $4.04 | 49 861 |
| 2022-12-12 | $3.87 | $4.18 | $3.81 | $4.05 | 178 825 |
| 2022-12-09 | $4.06 | $4.16 | $3.72 | $3.81 | 194 407 |
| 2022-12-08 | $4.09 | $4.16 | $4.07 | $4.07 | 45 466 |
| 2022-12-07 | $4.11 | $4.20 | $4.05 | $4.12 | 84 935 |
| 2022-12-06 | $4.23 | $4.23 | $4.05 | $4.08 | 54 306 |
| 2022-12-05 | $4.50 | $4.50 | $4.17 | $4.18 | 102 573 |
| 2022-12-02 | $4.34 | $4.60 | $4.28 | $4.55 | 107 253 |
| 2022-12-01 | $4.55 | $4.62 | $4.31 | $4.33 | 201 548 |
| 2022-11-30 | $4.01 | $4.68 | $4.01 | $4.47 | 426 799 |
| 2022-11-29 | $3.90 | $4.03 | $3.85 | $4.02 | 119 772 |
| 2022-11-28 | $4.11 | $4.24 | $3.91 | $3.94 | 107 532 |
| 2022-11-25 | $4.19 | $4.19 | $4.01 | $4.07 | 48 884 |
| 2022-11-23 | $4.12 | $4.20 | $4.11 | $4.13 | 45 540 |
| 2022-11-22 | $4.12 | $4.19 | $4.00 | $4.06 | 66 362 |
| 2022-11-21 | $4.06 | $4.24 | $3.97 | $4.18 | 96 857 |
| 2022-11-18 | $3.92 | $4.10 | $3.90 | $4.08 | 61 785 |
| 2022-11-17 | $3.98 | $4.00 | $3.86 | $3.87 | 126 915 |
| 2022-11-16 | $4.09 | $4.11 | $3.93 | $4.04 | 116 638 |
| 2022-11-15 | $4.18 | $4.28 | $4.03 | $4.17 | 185 725 |
| 2022-11-14 | $4.50 | $4.57 | $4.03 | $4.18 | 312 228 |
| 2022-11-11 | $4.68 | $4.82 | $4.53 | $4.55 | 143 060 |
| 2022-11-10 | $4.68 | $4.95 | $4.66 | $4.94 | 80 481 |
| 2022-11-09 | $4.90 | $4.90 | $4.70 | $4.71 | 98 228 |
| 2022-11-08 | $4.94 | $5.01 | $4.85 | $4.89 | 59 582 |
| 2022-11-07 | $4.96 | $5.07 | $4.82 | $4.94 | 112 259 |
| 2022-11-04 | $5.20 | $5.20 | $4.87 | $4.95 | 133 006 |
| 2022-11-03 | $5.00 | $5.31 | $4.92 | $5.14 | 149 785 |
| 2022-11-02 | $5.40 | $5.43 | $5.02 | $5.08 | 241 715 |
| 2022-11-01 | $5.60 | $5.60 | $5.31 | $5.44 | 144 817 |
| 2022-10-31 | $5.59 | $5.74 | $5.52 | $5.56 | 73 610 |
About Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
